Tumor recurrence can be caused by high immunosuppressant levelsHigh levels of the immunosuppressant cyclosporine favor tumor recurrence as per a study on the incidence of liver cancer. The study was also able to identify blood levels of the drug that must not exceed besides identifying that low cyclosporine levels have no effect on the rejection rates.

The study results appeared in an issue of Liver Transplantation, the official journal of the American Association for the Study of Liver Diseases (AASLD) and the International Liver Transplantation Society (ILTS).

The journal was published on behalf of the societies by John Wiley & Sons, Inc. and is available online via Wiley InterScience.